ADAM17 Antibody (LS-B1821)

貨號 Cat. No.
LS-B1821
規格 Size
50 µg
品牌 Brand
LSBio

Description





















































































Antibody Catalog ID: LS-B1821
Antibody Validation: This antibody replaces catalog number LS-C46887. It has been validated for use in the following assays: IHC.
Antibody Target: A Disintegrin And Metalloproteinase Domain 17 (ADAM17/TACE)
Synonyms: ADAM17, adam17, CD156b antigen, cSVP, Snake venom-like protease, TACE, TNF alpha convertase, tnf-alpha converting enzyme, tumor necrosis factor alpha converting enzyme
Family: Protease
Subfamily: Metallopeptidase M12B
Host: ADAM17 antibody was produced in Rabbit
Antigen Species: ADAM17 antibody was raised against Human
Clonality: Polyclonal
Antigen Type: Synthetic peptide - KLH conjugated
Immunogen: ADAM17 antibody was raised against synthetic peptide
Antibody Specificity: synthetic peptide corresponding to C-terminal residues of human ADAM 17 (a disintegrin and metalloproteinase domain 17 isoform 1 preproprotein)
Antigen Modification: C-Terminus
Purification: Immunoaffinity Chromatography
Presentation: PBS, 0.01% sodium azide, 50% glycerol.
Recommended Storage: +4°C or -20°C, Avoid repeated freezing and thawing.
Antibody Usage Summary: Immunohistochemistry: LS-B1821 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D1, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B1821 was determined to be 20 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (20 µg/ml), Western blot (WB) (1 µg/ml), ELISA (1 µg/ml) (Optimal dilution to be determined by the researcher)
Size: 50 µg
Concentration: 0.5 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢